We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 03, 2019

NOAC- vs VKA-Based Double Therapy in Stented Patients With Atrial Fibrillation

Circulation: Cardiovascular Interventions

 

Additional Info

Circulation: Cardiovascular Interventions
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial
Circ Cardiovasc Interv 2019 Nov 01;12(11)e008160, M Kerneis, MK Yee, R Mehran, T Nafee, C Bode, JL Halperin, ED Peterson, FWA Verheugt, P Wildgoose, M van Eickels, GYH Lip, M Cohen, KAA Fox, CM Gibson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading